Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Immune cells in reproductive tract
  • Track 1-2Sex hormones & immune system
  • Track 1-3Developmental changes in immune system
  • Track 1-4Effect of age on immune system
  • Track 2-1Innate immunity
  • Track 2-2Adaptive immunity
  • Track 2-3T-cells & B-cells
  • Track 2-4Lymphoid organs
  • Track 2-5Lymphocyte development & activation
  • Track 2-6Antigen presentation & processing
  • Track 2-7Immune diversity
  • Track 2-8Cellular interactions
  • Track 3-1Skin Immunology
  • Track 3-2Respiratory immunology
  • Track 3-3Gastrointestinal immunology
  • Track 3-4Occular immunology
  • Track 3-5Neuro immunology
  • Track 3-6Osteoimmunology
  • Track 4-1Antibody structure
  • Track 4-2Antibody classes
  • Track 4-3Antigen response in different tissues
  • Track 4-4Antigen-Antibody complexes
  • Track 5-1Types of vaccines
  • Track 5-2Vaccine vehicles
  • Track 5-3Vaccine safety
  • Track 5-4Transfusion Alternatives
  • Track 6-1Assays for Antigen & antibody
  • Track 6-2Isolation of cells
  • Track 6-3Monoclonal Antibodies
  • Track 6-4Cytometry
  • Track 6-5DNA Microarrays
  • Track 6-6Measurement of immune function
  • Track 6-7Agglutination tests
  • Track 7-1Immunity to Infection
  • Track 7-2Immunity to viruses
  • Track 7-3Immunity to Bacteria & fungi
  • Track 7-4Immunity to protozoa & worms
  • Track 7-5Microbial immunology
  • Track 7-6Immunogens & Antigens
  • Track 8-1Origin & host defence against tumours
  • Track 8-2Cytokine and cellular immunotherapy of tumours
  • Track 8-3Immune response to tumours
  • Track 8-4Tumour antigens
  • Track 8-5Immuno diagnostics of cancer
  • Track 8-6Tumor vaccines
  • Track 8-7Immunotherapy of tumours with antibodies
  • Track 9-1Cell mediated Immunotherapy
  • Track 9-2Cytokine mediated immunotherapy
  • Track 9-3Antibody mediated immunotherapy
  • Track 9-4Cellular immunotherapy
  • Track 10-1Gene Mapping
  • Track 10-2Genes of immunoglobulin
  • Track 10-3Major Histocompatibility Complex
  • Track 10-4Advances in immunogenetics
  • Track 11-1ABO & Rh blood groups
  • Track 11-2Blood transfusion
  • Track 11-3Transfusion hazards
  • Track 12-1Tissue damage
  • Track 12-2Disease pathogenesis
  • Track 13-1Immune Deficiency
  • Track 13-2Hypersensitivity
  • Track 13-3Autoimmune diseases
  • Track 13-4Transplantation & Rejection
  • Track 13-5Immune pharmacotherapy
  • Track 13-6Immunity & Malnutrition
  • Track 13-7HLA system
  • Track 14-1Central Immune tolerance
  • Track 14-2Pheripheral immune tolerance